About Dallas Renal Group
"Dallas Renal Group provides professional, courteous, compassionate, convenient and state of the art medical care. Our mission is to empower you and your family with knowledge and necessary skills to better appreciate your medical conditions so that you can make choices that will enable you to lead a healthy life. Dallas Renal Group's board-certified Nephrologists providing care to patients with Kidney related health issues in Dallas Metroplex Since 2005."
Clinical Trials at Dallas Renal Group
During the past decade, Dallas Renal Group conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Dallas Renal Group"
#1 collaborator was "Akebia Therapeutics Inc." with 1 trials as a collaborator and "Biocon Limited" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Dallas Renal Group
According to Clinical.Site data, the most researched conditions in "Dallas Renal Group" are
"Anemia, Iron Deficiency" (1 trials), "Arteriovenous Fistula" (1 trials), "Hyperphosphatemia" (1 trials), "Lupus Erythematosus" (1 trials) and "Lupus Nephritis" (1 trials). Many other conditions were trialed in "Dallas Renal Group" in a lesser frequency.
Clinical Trials Intervention Types at Dallas Renal Group
Most popular intervention types in "Dallas Renal Group" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Covera Vascular Covered Stent" (1 trials), "Ferric Citrate 1 gram Oral Tablet" (1 trials), "Finerenone (BAY94-8862)" (1 trials), "Itolizumab [Bmab 600]" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Dallas Renal Group
The vast majority of trials in "Dallas Renal Group" are
4 trials for "All" genders.
Clinical Trials Status at Dallas Renal Group
Currently, there are NaN active trials in "Dallas Renal Group".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 1 completed trials in Dallas Renal Group,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Dallas Renal Group, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".